Boston Scientific EVP exercises RSUs, withholds shares

BOSTON SCIENTIFIC CORP executive Arthur C. Butcher reported routine equity compensation activity.

Rhea-AI Filing Summary

BOSTON SCIENTIFIC CORP executive Arthur C. Butcher reported routine equity compensation activity. On May 2, 2026, he exercised 2,102 Restricted Stock Units, receiving the same number of common shares. These RSUs each represent a commitment to issue one share of Boston Scientific common stock.

To cover tax obligations, 1,007 common shares were disposed of through a tax-withholding transaction at $56.50 per share, which is not an open-market sale. After these transactions, he holds 56,887 common shares directly and 20,228 shares indirectly through the company’s 401(k) Retirement Savings Plan.

Insider Trade Summary

2,102 shares exercised/converted

Exercise 4 txns

Insider Butcher Arthur C

Role EVP& Grp Pres, MedSurg & APAC

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,102	$0.00	$0.00
Exercise	Common Stock	2,102	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,007	$56.50	$57K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 56,887 shares (Direct); Common Stock — 20,228 shares (Indirect, By 401(k))

Footnotes (3)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
3. F3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.

Key Figures

RSUs exercised: 2,102 units Shares withheld for taxes: 1,007 shares Tax-withholding price: $56.50 per share +3 more

6 metrics

RSUs exercised 2,102 units Restricted Stock Units converted to common stock on May 2, 2026

Shares withheld for taxes 1,007 shares Tax-withholding disposition coded F at $56.50 per share

Tax-withholding price $56.50 per share Price for 1,007-share tax-withholding disposition

Direct holdings after transactions 56,887 shares Common stock directly owned following reported Form 4 events

401(k) plan holdings 20,228 shares Indirect ownership via company 401(k) Retirement Savings Plan

RSU conversion price $0.00 RSUs converted to common stock with no exercise price

Key Terms

Restricted Stock Units, tax-withholding disposition, 401(k) Retirement Savings Plan, derivative exercise/conversion, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit represents the Company's commitment to issue one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"Payment of exercise price or tax liability by delivering securities"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

401(k) Retirement Savings Plan financial

"share holdings in the Company's 401(k) Retirement Savings Plan"

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

indirect ownership financial

"direct_or_indirect": "I", "nature_of_ownership": "By 401(k)""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BSX executive Arthur C. Butcher report on this Form 4?

Arthur C. Butcher reported routine equity compensation activity, exercising 2,102 Restricted Stock Units into common shares. As part of the same event, 1,007 shares were withheld to satisfy tax obligations, and his resulting direct and 401(k) share holdings were updated.

How many Boston Scientific (BSX) shares did Arthur C. Butcher acquire and dispose?

He acquired 2,102 Boston Scientific common shares through the vesting and conversion of Restricted Stock Units. In a related tax-withholding transaction, 1,007 common shares were disposed of to cover tax obligations, rather than being sold in the open market.

What are Arthur C. Butcher’s BSX share holdings after these transactions?

Following the reported transactions, Arthur C. Butcher directly holds 56,887 shares of Boston Scientific common stock. In addition, 20,228 shares are indirectly held for his benefit through the company’s 401(k) Retirement Savings Plan, based on the most current plan data.

Was the 1,007-share BSX disposition an open-market sale?

No. The 1,007-share disposition was coded as an “F” transaction, meaning shares were withheld to pay the exercise price or tax liability. This represents a tax-withholding mechanism, not an open-market sale initiated to trade shares.

What do the Restricted Stock Units (RSUs) in this BSX Form 4 represent?

Each Restricted Stock Unit represents Boston Scientific’s commitment to issue one share of its common stock. In this filing, 2,102 RSUs were converted into 2,102 common shares as part of a scheduled vesting and exercise event for Arthur C. Butcher.

How are BSX shares held in Arthur C. Butcher’s 401(k) plan reported?

Shares held in the company’s 401(k) Retirement Savings Plan are reported as indirect ownership. The filing notes a balance of 20,228 Boston Scientific common shares, reflecting the most current data available from the plan’s records at the time of reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Butcher Arthur C

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP& Grp Pres, MedSurg & APAC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/02/2026		M		2,102	A	$0.0000(1)	57,894	D
Common Stock	05/02/2026		F		1,007	D	$56.5	56,887	D
Common Stock								20,228(2)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/02/2026		M			2,102	(3)	05/02/2026(3)	Common Stock	2,102	$0.0000	0.0000	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

3. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)